Product image of Tobi Podhaler (Tobramycin) supplied by GNH India

Tobi Podhaler

Active Ingredient:
Tobramycin
Origin:
EU

Tobi Podhaler (Tobramycin)

Tobi Podhaler is an inhaled antibiotic used to manage lung infections in cystic fibrosis patients. This dry powder formulation delivers tobramycin directly to the lungs for targeted action. Ideal for respiratory support and infection control.

Manufacturer / TM Owner

Viatris Healthcare Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Tobi Podhaler is used to treat lung infections caused by Pseudomonas aeruginosa in people with cystic fibrosis. It works by delivering the antibiotic directly to the lungs, where infections are most common. This helps reduce bacterial growth and improve respiratory symptoms. Patients often use it to manage chronic infections and maintain lung function.

Side Effects

  • This medication helps reduce the severity of lung infections and may improve breathing over time. Users often report fewer coughing episodes and clearer airways during treatment cycles. Regular use supports long-term respiratory health in cystic fibrosis management.

Precautions & Warnings

  • Store the Podhaler capsules in a dry place away from moisture. Always use the provided inhaler device as directed and keep it clean to ensure proper function. Discard any capsules that appear damaged or discolored. Consult a healthcare provider if you experience worsening symptoms or side effects.

Avoid Interactions

  • Certain medications, including strong diuretics or other antibiotics, may interact with tobramycin. Avoid using other inhaled medications at the same time unless directed by a doctor. Alcohol and tobacco use may reduce the effectiveness of treatment. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Tobi Podhaler is used to treat lung infections caused by Pseudomonas aeruginosa in people with cystic fibrosis.

It is taken using a special inhaler device that delivers the medication directly to the lungs as a dry powder.

Consult a healthcare provider before combining it with other inhaled or systemic medications to avoid interactions.

Common side effects may include cough, sore throat, or changes in voice. Severe reactions should be reported to a doctor.

It is prescribed for regular cycles to manage chronic infections, but regular medical supervision is required.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tobramycin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT